Welcome to our dedicated page for DOCUSIGN SEC filings (Ticker: DOCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on DOCUSIGN's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into DOCUSIGN's regulatory disclosures and financial reporting.
DocuSign, Inc. Chief Revenue Officer Paula Hansen reported multiple open-market sales of company common stock. On January 2, 2026, she sold a total of 6,000 shares of DocuSign common stock in four separate transactions, at reported prices of $65.43, $66.94, $67.78, and $68.62 per share.
The filing states that these sales were made under a pre-arranged Rule 10b5-1 trading plan adopted by Hansen, which is designed to allow insiders to sell shares according to a preset schedule. Following the reported sales, Hansen directly beneficially owned 68,970 shares of DocuSign common stock.
Docusign, Inc. reported that its Chief Legal Officer, James P. Shaughnessy, sold common stock in multiple transactions on 01/02/2026. He sold a total of 12,000 shares of Docusign common stock in four separate sales, at prices generally between $64.97 and $68.68, as reflected by the detailed price ranges in the footnotes. These sales were executed pursuant to a Rule 10b5-1 trading plan previously adopted by Shaughnessy. Following the reported transactions, he beneficially owned 54,550 shares of Docusign common stock directly.
DocuSign, Inc. director reported an insider transaction involving company common stock. On 12/10/2025, the reporting person made a transaction coded "G" (a gift) of 15,000 shares of common stock at a stated price of $0, held indirectly through a trust.
After this transaction, the reporting person beneficially owned 120,253 shares of DocuSign common stock indirectly through a trust, in addition to 7,512 shares held directly, 65,558 shares held indirectly by children's trusts, 6,458 shares held indirectly by a spouse, and 3 shares held indirectly through a family partnership.
DocuSign, Inc. Chief Financial Officer, identified as an officer of the company, reported multiple equity transactions in December 2025. On 12/15/2025, the CFO acquired 37,453 shares of common stock at $0 through the vesting and settlement of restricted stock units (RSUs) and performance stock units (PSUs), and 15,385 shares were withheld to cover tax obligations. Following these transactions, the CFO directly held 127,728 shares of common stock.
On 12/17/2025, the CFO sold 3,525 shares at an average price within a range of $67.31 to $68.29, and 5,990 shares at prices ranging from $68.33 to $69.05, under a pre-established Rule 10b5-1 trading plan. The filing also details ongoing RSU and PSU awards that vest over several years or based on DocuSign’s FY25 subscription revenue and free cash flow performance.
DocuSign's chief legal officer reported multiple stock-based compensation events on December 15, 2025. Several batches of restricted stock units (RSUs) and performance stock units (PSUs) converted into common stock at an exercise price of $0, adding 20,968 shares of common stock.
To cover taxes on these vestings, 9,860 shares were withheld by the company, reducing the net increase in directly held stock. After the reported transactions, the officer directly owned 66,550 shares of DocuSign common stock. The filing also details remaining RSU and PSU awards that continue to vest over time based on service and performance conditions tied to subscription revenue and free cash flow for specified performance periods.
DocuSign, Inc.’s Chief Revenue Officer reported equity award activity involving company stock. On 12/15/2025, the executive acquired 32,515 shares of DocuSign common stock at $0 following the vesting and settlement of restricted stock units (RSUs) and performance stock units (PSUs). To cover tax obligations triggered by this vesting, 16,513 shares were withheld by the company, also at $0 per share. After these transactions, the officer directly beneficially owned 74,970 shares of common stock. The filing also shows continuing holdings of RSUs and PSUs that may convert into additional shares over time, subject to time-based vesting, performance targets tied to subscription revenue and free cash flow for the FY25 performance period, and continued service conditions.
DocuSign, Inc. reported insider stock activity by its President and General Manager, Growth. On December 15, 2025, the executive sold 1,683 shares of common stock at $70.87 per share under a Rule 10b5-1 trading plan. That same day, vested equity awards were exercised, adding 31,538 shares, and the company withheld 16,019 shares at no price to cover tax obligations from vesting restricted and performance stock units.
On December 17, 2025, the executive completed additional open-market sales of 5,253 shares at an average price of $67.88 and 8,565 shares at an average price of $68.61, with exact prices ranging from $67.31 to $69.05. Following these transactions, the executive directly held 70,197 shares of DocuSign common stock, along with multiple tranches of restricted stock units and performance stock units that may convert into shares over time based on service and performance conditions.
DocuSign, Inc. President and CEO, who also serves as a director, reported equity award activity dated 12/15/2025. The filing shows the exercise and settlement of restricted stock units into 65,561 shares of common stock, with 33,296 shares withheld to cover tax obligations, leaving 168,511 shares of common stock held directly after the transactions.
Multiple grants of restricted stock units and performance stock units remain outstanding, each convertible into common stock at an exercise price of $0. These awards vest over multi‑year schedules, generally in quarterly installments, conditioned on continued service and, for performance stock units, on achieving subscription revenue and free cash flow targets for the FY24 and FY25 performance periods, with potential vesting capped at 200% of target.
DocuSign, Inc. reported that one of its officers, listed as President General Mgr, Growth, sold 983 shares of common stock on 12/11/2025.
The sale was executed at a price of $68.62 per share under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person, and was coded as a sale transaction. After this trade, the officer beneficially owns 70,179 shares of DocuSign common stock, held directly.
Reporting person: Paula Hansen, Chief Revenue Officer at DocuSign, Inc. (DOCU). The filing shows an ESPP purchase and several sales under a Rule 10b5-1 plan. On 10/03/2025 Ms. Hansen acquired 245 shares through the 2018 Employee Stock Purchase Plan at an effective price of $59.27 per share. On 10/07/2025 she sold a total of 6,000 shares in three transactions at weighted prices in the $70.23–$72.80 range, reducing her beneficially owned shares from 64,968 to 58,968. The sales are reported as made pursuant to a Rule 10b5-1 plan and price ranges per tranche are disclosed in the remarks.